98%
921
2 minutes
20
Background: Intraoperative transesophageal echocardiography (IOTEE) is well established as a monitoring tool during ventricular septal defect (VSD) repair to ensure complete closure of the defect. Residual shunts detected by IOTEE are common. The predictive value of IOTEE findings on the long-term course of residual shunts is not well documented, especially in regard to the need for reoperation or bacterial endocarditis prophylaxis. The objective of this study is to determine the predictive value of intraoperative IOTEE diagnosis of residual VSDs and therefore delineating the natural history of these findings.
Methods: Retrospective review of IOTEE reports of 690 consecutive patients with VSD (isolated or part of a complex lesion) was undertaken. Those were compared with transthoracic echocardiographic reports of these patients before their discharge from the hospital, and the most recent transthoracic echocardiographic examination. Positive and negative predictive values, sensitivity, and specificity of such diagnoses were then calculated from predischarge and from follow-up transthoracic echocardiographic data.
Results: There were 260 of 690 patients with a residual VSD on IOTEE; 24 required repeat cardiopulmonary bypass for complete closure. There were 573 patients with predischarge transthoracic echocardiographic examination; 296 had residual VSDs (125 not detected by IOTEE), and 13 defects required reoperation during the same hospitalization, 5 of which were detected by IOTEE. The positive and negative predictive values were 78% and 65%, respectively. Follow-up transthoracic echocardiographic examination of 383 local patients showed residual VSD in 57 (37 not detected by IOTEE), with positive and negative predictive values of 15% and 83%, respectively.
Conclusions: Although IOTEE is sensitive enough to detect residual VSD shunts in many patients (37% of this cohort), the majority of these defects are trivial and resolve spontaneously, with a positive predictive value of only 15% on follow-up transthoracic echocardiographic examination and a rare need for reoperation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.athoracsur.2009.10.058 | DOI Listing |
J Med Cases
August 2025
Department of Cardiology, Angiology, and Intensive Care Medicine, Philipps-Universitat Marburg, Germany.
Quadricuspid aortic valve (QAV) is a rare congenital anomaly with an estimated incidence of 0.008% to 0.043% based on autopsy and echocardiographic studies.
View Article and Find Full Text PDFInt J Cardiovasc Imaging
September 2025
Department of Cardiology, Westmead Hospital, Western Sydney Local Health District, Parramatta, NSW, Australia.
Left atrial strain (LAS) is a valuable echocardiographic marker of left atrial function with growing clinical utility. However, variability in LAS measurements across software vendors remains a barrier to its routine clinical use. This study aimed to compare LAS measurements obtained using a dedicated left atrial-specific measurement tool (AFI-LA (General Electric (GE)) with those derived from established LV-based strain platforms: GE EchoPAC (mid-myocardial and endocardial tracking) and TomTec-Arena (feature tracking), used for measurement of LAS.
View Article and Find Full Text PDFBMC Pregnancy Childbirth
September 2025
Institute of Tropical Medicine of Rio Grande Do Norte, Av. Senador Salgado Filho, 3000, Campus Universitário, Natal, RN, Brazil.
Background: Hypertensive disorders of pregnancy, including preeclampsia, are common in socioeconomic vulnerable populations worldwide. Approximately one third of women who have those disorders will maintain with hypertension, after pregnancy. This work aimed to determine the prevalence of hypertensive disorder of pregnancy in Natal, Brazil, and to use echocardiography to study cardiac function: (1) during pregnancy, and (2) at post partum in those who developed severe preeclampsia.
View Article and Find Full Text PDFAm J Cardiol
August 2025
Division of Cardiovascular Diseases and Hypertension, Rutgers University - Robert Wood Johnson Medical School, 125 Paterson Street, East Tower - 8th Floor, New Brunswick, New Jersey 08901, United States. Electronic address:
The use of left ventricular assist devices (LVADs) has increased in recent years as a destination therapy. The HeartMate 3 (HM3) is currently the only commercially available LVAD for implantation in the United States. Societal guidelines for multimodality cardiac imaging evaluation of LVADs and temporary mechanical support devices were recently published and serve as a comprehensive resource for the evaluation of LVAD patients.
View Article and Find Full Text PDFCureus
July 2025
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA.
Background Exploring longitudinal associations of blood biomarkers with left atrial (LA) structure and function can enhance our understanding of atrial fibrillation (AF) etiopathogenesis. Methods We studied 532 participants of the PREDIMED-Plus trial, a multicenter randomized trial in overweight and obese adults with metabolic syndrome. At baseline, 3 and 5 years after randomization, participants underwent transthoracic echocardiography and provided blood for serum biomarker measurements (propeptide of procollagen type I (PICP), high-sensitivity (hs) troponin T (hsTnT), hs C-reactive protein (hsCRP), 3-nitrotyrosine (3-NT), and N-terminal propeptide of B-type natriuretic peptide (NT-proBNP)).
View Article and Find Full Text PDF